9
neurodegeneration that underlies memory loss, however the spatial origins of the lesions remain 2 0
elusive. Using SWITCH, we created a spatiotemporal map of Aβ deposition in a mouse model of 2 1 amyloidosis. We report that structures connected by the fornix show primary susceptibility to Aβ 2 2 accumulation and demonstrate that aggregates develop in increasingly complex networks with 2 3 age. Notably, the densest early Aβ aggregates occur in the mammillary body coincident with 2 4 electrophysiological alterations. In later stages, the fornix itself also develops overt Aβ burden.
5
Finally, we confirm Aβ in the mammillary body of postmortem patient specimens. Together, our 2 6 data suggest that subcortical memory structures are particularly vulnerable to Aβ deposition and 2 7 that functional alterations within and physical propagation from these regions may underlie the 2 8 affliction of increasingly complex networks. of aggregate forms of the peptide on neural substrate, which suggests they directly influence the 4 5 neurodegeneration observed in different subtypes of AD. [5] [6] [7] In addition to cellular harm,
6
amyloidosis in murine models of AD contributes to AD-like memory impairments, hippocampal 4 7
synaptic loss, and electrophysiological alterations --changes that are also observed in human 4 8
patients. [8] [9] [10] This data not only links lesions to dementia in FAD, but also provides a basis for 4 9
understanding the etiology of the sporadic form of the disease. Despite the link between amyloid 5 0 toxicity and neurodegeneration, the precipitating events that trigger Aβ accumulation,
1
deposition, and propagation which initiate AD remain unclear.
2 3
One impediment to understanding Aβ deposition has been identifying the brain regions most
4
vulnerable to Aβ plaques. The first studies using postmortem brain sections from AD patients'
5
brains suggested that primary accumulation occurs in the neocortex with subsequent spread of 5 6
aggregates to deeper structures implicated in learning and memory. anterior cingulate cortex; RSP, retrosplenial cortex; vSub, ventral subiculu; LS, lateral septum; dSub, dorsal subiculum; MC, motor cortex; DB, diagonal band; MS, medial septum; ACB, nucleus accumbens; PIR, piriform cortex; MD, midbrain; Thal, thalamus; BLA, basolateral amygdala; OT, olfactory tubercle; PERI, perirhinal and ectorhinal corticies; GC, gustatory cortex; IC, insular cortex; VIS, visual cortex; PTL, posterial parietal association areas; SS, somatosensory cortex; DP, dorsal peduncular area; AON, anterior olfactory nucleus; EC, entorhinal cortex; PFC, prefrontal cortex; OFC, orbitofrontal cortex; TR, postpiriform transition area; TT, taenia tecta; dDG, dorsal dentate gyrus; Visc, visceral cortex; TEA, temporal association areas; AUD, auditory cortex; dCA1, dorsal CA1, vDG, ventral dentate gyrus; vCA1, ventral CA1; vCA3, ventral CA3; dCA3, dorsal CA3; CP, caudoputamen; BNST, bed A. C) The action potential threshold of the cells does not change, neither does the D) after-hyperpolarization. E) The action potential amplitude is significantly decreased in 5XFAD animals and F) the resting membrane potential is also significantly decreased, both of which could underlie the excitability phenotype. Figure 3A ). We cut traditional histology sections from the 2 2 9 blocks ( Figure 3B ) that revealed numerous Aβ deposits in the MB of AD patients at each stage, 2 3 0 with none present in the healthy individual ( Figure 3C, 3D ). This finding is consistent with older 2 3 1
reports of amyloid pathology in the region. 43 However, because the sections were thin and the 2 3 2 deposits did not label strongly, we could not determine whether there was a stage-dependent ( Figure 3G ). This suggests substantial early Aβ deposition precedes overt dementia and that 2 3 9
aggregates continue to expand as the largest ones in our small cohort were seen in the Braak V To check whether this is reflected in the 5XFAD model, we investigated the Aβ burden in major 2 4 6 forebrain white matter tracts. We did not observe Aβ in the white matter of 2M animals, but did 2 4 7 observe consistent deposits in the fornix of the 6M cohort ( Figure 4A, Video 2c) Hoechst 33528 was used for nuclear labeling (Sigma #14530).
9 2
All secondary antibodies were Pre-adsorbed F(ab)2' AlexaFluor-conjugated from AbCam. Table 1 . Primer sequences (5'-3') for in situ probe preparation.
0 6
Ex vivo electrophysiology 5 0 7
Acute hippocampal slices were prepared from C57bl/6 mice aged2-2.5 months old， which are 5 0 8
wild type group and 5xFAD group. The mice were anesthetized with isoflurane and decapitated.
0 9
The experimenter was blinded to the group of animal. Transverse brain slices (250 μ m thick) 5 1 0
were prepared in ice-cold dissection buffer (in mM: 211 sucrose, 3.3 KCl, 1.3 NaH2PO4, 0.5
CaCl2, 10 MgCl2, 26 NaHCO3 and 11 glucose) using a Leica VT1000S vibratome (Leica).
1 2
Slices were recovered in a submerged chamber with 95% O2/5% CO2-saturated artificial 5 1 3
cerebrospinal fluid (ACSF) consisting of (in mM) 124 NaCl, 3.3 KCl, 1.3 NaH2PO4, 2.5 CaCl2, 5 1 4
1.5 MgCl2, 26 NaHCO3 and 11 glucose for 1 h at 28-30 °C. Whole cell patch clamp with 5 1 5 current steps from 0 pA to +130 pA at 10 pA increments for 800ms were used to verify the 5 1 6
ability to form action potential (AP) on HEKA ECP 10 Amplifier (Germany) with Pulse software.
1 7
Number of APs at each current step; Resting membrane potential (RMP); Threshold of APs;
1 8
Amplitude of APs from RMP and threshould as well as fast afterhyperpolarization(fAHP) were 5 1 9 measured and analyzed. , and last (right) slices of z-stack image files taken from tissue labeled for myelin basic protein (MBP, red) glial fibrillary acidic protein (GFAP, green), and with Hoechst dye (blue) using either iSWITCH buffers (top) or tradititional labeling buffer phosphate buffered saline with triton x-100 (PBST, bottom). B) Quantification of MBP labeling demonstrating signal inensity consistency between the first and last sections under both conditions (left), but enhanced middle section immunolabeling signal when compared to either the intensity of the first (center) or last (right) section. C) Immunofluorescent signal loss throughout the depth of the sections is first order decay using iSWITCH buffers, indicating relatively homogenous signal with intensity that decays with depth due to laser attenuation, but using PBST the loss is a second order polynomial, indicating non-homogenous signal intensity through the thickness of the tissue. *p ≤ 0.05; **p ≤ 0.01; ****p≤ 0.0001; Graphs report Mean ± Standard Deviation. β -amyloid achieves homogenous signal. Aged 5XFAD brain was split into two hemispheres and labeled with either iSWITCH buffers or PBST. A) Representative images from the center section of each hemisphere. B) Demonstration of the consistency of overall aggregate counts between animals and no consistent effect of PBST or iSWITCH on aggregate detection. C) Aggregates labeled by iSWITCH show overall lower intensity, which may be driven by more antibody availability for surface antigens. D) Plot of the intensity of aggregates detected through sample (left axis) with regression (right axis) showing non-homogenous signal intensities in PBST labeled brains, which is rectified using iSWITCH buffers. Graphs report Mean ± Standard Deviation unless otherwise noted in the text. 
